Global Heparin Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Apr 2019
  • Global
  • 350 Pages
  • No of Tables: 618
  • No of Figures: 60

Global Heparin Market By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)}, Mode of Administration (Oral Administration, Parenteral  Administration), Source (Bovine, Porcine), Ingredients(Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others),  Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others),  Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others),   Type (Generics, Brands),  Container (Bottles, Bags, Vials, Others),  Packaging (Glass, Plastic),  End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Store, Online Pharmacy, Others), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa) – Industry Trends & Forecast to 2026

Heparin is medication is used to prevent and treat blood clots. It is used to treat blood clotting disorders. It is also used to prevent blood clots after surgery, during blood transfusions, dialysis, and blood samples. It helps in smooth blood flowing by releasing anti-clotting protein. It is known as an anticoagulant. It is also used in diagnose and treatment of disseminated intravascular coagulation, deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It cannot dissolve blood clots but only prevent the clots from becoming larger and causing more serious problems. Heparin is an animal-derived product, derived from mucosal tissues of slaughtered meat animals.

Heparin is used for Diagnosis of heart attacks and unstable angina, Inhibition of cancer, metabolic disorders, and hepatitis, as an anti-inflammatory drug in injuries as Anti-Coagulants in blood sampling.

Global heparin market is projected to register a substantial CAGR of 5.7% in the forecast period 2019 to 2026.

Market Segmentation: Global Heparin Market

Global heparin market is segmented into fourteen notable segments which are product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, brands, Type, container, packaging, end user, distribution channel. 

  • On the basis of product type, the market is segmented into unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH)

    • In September 2018, SANOFI (France) announced Health Canada’s approval of a new indication for Lovenox (LMWH) for the prevention of thrombus formation in the extra-corporeal circulation during hemodialysis in patients with end stage kidney disease (ESKD). This will attract the potential consumers helping in the growth of the company.

  • On the basis of mode of administration, the market is segmented into oral administration and parenteral administration
  • On the basis of source, the market is segmented into bovine and porcine
  • On the basis of ingredients, the market is segmented into sodium and calcium and others

    • In December 2016, Fresenius Kabi lunched Heparin Sodium Injection 5,000 USP units/mL. It is an anticoagulant to prevent clotting of blood and the formation of fibrin clots both in vitro and in vivo.

  • On the basis of availability, the market is segmented into raw, and processed
  • On the basis of treatment, the market is segmented into deep vein thrombosis, pulmonary embolism, arterial thromboembolism and others
  • On the basis of application, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis, diagnostic tests and others
  • On the basis of therapeutics, the market is segmented into cardiovascular, respiratory, oncology, nephrology, CNS and others
  • On the basis of strength, the market is segmented into 10 unit, 100 unit, 1000 unit, 5000 unit, 10000 unit, 25000 unit and others
  • On the basis of type, the market is segmented into generics and brands

    • In February 2015, Pfizer Inc. spent USD 17,000 million to acquire Hospira which deals with biosimilars—generic versions of biologic drugs, made from living cells biologic drugs. The deal includes the commercial rights for anticoagulant heparin sodium which will help the company in generating the revenue and growth in the heparin market.

  • On the basis of container, the market is segmented into bottles, bags, vials and others. On the basis of packaging, the market is segmented into glass and plastic
  • On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy & drug store, online pharmacy and others

Competitive Analysis: Global Heparin Market

  • Some of the major players operating in this market are Sanofi, Pfizer Inc, F. Hoffmann-La Roche Ltd , Mylan N.V., Aspen Holdings, changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, LEO Pharma A/S, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., Novartis AG, OPOCRIN S.P.A, SARIA SE & Co. KG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Yino Pharma Limited, and among others.

Recent Developments:

  • In August 2015, Leo Pharma A/S released a study report that showed innohep lowered the risk of recurrent venous thromboembolism (VTE) compared to treatment with warfarin in cancer patients with symptomatic venous thromboembolism. The study also showed that innohep reduced non-major bleeding as compared to warfarin. The company is expanding the business by entering into a new indication.
  • In March 2019 Bioiberica's Business Unit participated in DCAT 2019 with the objective of establishing strategic alliances and find new business opportunities in the US market. By these conferences the company will grow in the market by developing alliances.

Research Methodology: Global Heparin Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

TABLE 1 GLOBAL HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 2 GLOBAL UNFRACTIONATED HEPARIN IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 3 GLOBAL LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 GLOBAL LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEPARIN MARKET, BY PRODUCT TYPE, 2016-2026 (USD MILLION)

TABLE 5 GLOBAL ULTRA LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 GLOBAL ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) IN HEPARIN MARKET, BY TYPE, 2016-2026 (USD MILLION)

TABLE 7 GLOBAL HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 8 GLOBAL ORAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 GLOBAL PARENTERAL ADMINISTRATION IN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 10 GLOBAL PARENTRAL IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 GLOBAL HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 12 GLOBAL BOVINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 GLOBAL PORCINE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 GLOBAL HEPARIN MARKET, BY INGREDIENTS, 2016-2026 (USD MILLION)

TABLE 15 GLOBAL SODIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 GLOBAL CALCIUM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 GLOBAL OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 GLOBAL HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 19 GLOBAL RAW IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 TABLE1 GLOBAL PROCESSED IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 GLOBAL HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 22 GLOBAL DEEP VEIN THROMBOSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 GLOBAL PULMONARY EMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 GLOBAL ARTERIAL THROMBOEMBOLISM IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 GLOBAL OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 GLOBAL HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 27 GLOBAL PRE-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 GLOBAL POST-SURGICAL PROCEDURES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 GLOBAL KIDNEY DIALYSIS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 GLOBAL DIAGNOSTIC TEST IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 GLOBAL OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 GLOBAL HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 33 GLOBAL CARDIOVASCULAR IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 GLOBAL RESPIRATORY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 GLOBAL ONCOLOGY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 GLOBAL NEPHROLOGY IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 37 GLOBAL CNS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 GLOBAL OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 39 GLOBAL HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 40 GLOBAL 10 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 41 GLOBAL 100 UNIT IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 42 GLOBAL 1000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 43 GLOBAL 5000 UNITS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 44 GLOBAL 10000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 45 GLOBAL 25000 UNITS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 46 GLOBAL OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 47 GLOBAL GENERICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 48 GLOBAL HEPARIN MARKET, BY BRANDED, 2017-2026 (USD MILLION)

TABLE 49 GLOBAL BRANDEDS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 50 GLOBAL HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 51 GLOBAL BOTTLES IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 52 GLOBAL BAGS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 53 GLOBAL VIALS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 55 GLOBAL HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 56 GLOBAL GLASS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 57 GLOBAL PLASTIC IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 58 GLOBAL HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 59 GLOBAL HOSPITALS IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 60 GLOBAL CLINICS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 61 GLOBAL HOMECARE IN HEPARIN MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 62 GLOBAL AMBULATORY SURGICAL CENTERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 63 GLOBAL OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 64 GLOBAL HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 65 GLOBAL HOSPITAL PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 66 GLOBAL RETAIL PHARMACY & DRUG STORE IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 67 GLOBAL ONLINE PHARMACY IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 68 GLOBAL OTHERS IN HEPARIN MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 69 GLOBAL HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 70 NORTH AMERICA HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 71 NORTH AMERICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 72 NORTH AMERICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 73 NORTH AMERICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 74 NORTH AMERICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 75 NORTH AMERICA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 76 NORTH AMERICA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 77 NORTH AMERICA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 78 NORTH AMERICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 79 NORTH AMERICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 80 NORTH AMERICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 81 NORTH AMERICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 82 NORTH AMERICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 83 NORTH AMERICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 84 NORTH AMERICA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 85 NORTH AMERICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 86 NORTH AMERICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 87 NORTH AMERICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 88 NORTH AMERICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 89 U.S. HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 90 U.S. LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 91 U.S. ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 92 U.S. HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 93 U.S. PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 94 U.S. HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 95 U.S. HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 96 U.S. HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 97 U.S. HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 98 U.S. HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 99 U.S. HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 100 U.S. HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 101 U.S. HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 102 U.S. BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 103 U.S. HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 104 U.S. HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 105 U.S. HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 106 U.S. HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 107 CANADA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 108 CANADA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 109 CANADA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 110 CANADA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 111 CANADA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 112 CANADA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 113 CANADA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 114 CANADA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 115 CANADA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 116 CANADA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 117 CANADA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 118 CANADA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 119 CANADA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 120 CANADA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 121 CANADA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 122 CANADA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 123 CANADA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 124 CANADA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 125 MEXICO HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 126 MEXICO LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 127 MEXICO ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 128 MEXICO HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 129 MEXICO PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 130 MEXICO HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 131 MEXICO HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 132 MEXICO HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 133 MEXICO HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 134 MEXICO HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 135 MEXICO HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 136 MEXICO HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 137 MEXICO HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 138 MEXICO BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 139 MEXICO HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 140 MEXICO HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 141 MEXICO HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 142 MEXICO HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 143 EUROPE HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 144 EUROPE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 145 EUROPE LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 146 EUROPE ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 147 EUROPE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 148 EUROPE PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 149 EUROPE HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 150 EUROPE HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 151 EUROPE HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 152 EUROPE HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 153 EUROPE HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 154 EUROPE HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 155 EUROPE HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 156 EUROPE HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 157 EUROPE BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 158 EUROPE HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 159 EUROPE HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 160 EUROPE HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 161 EUROPE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 162 GERMANY HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 163 GERMANY LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 164 GERMANY ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 165 GERMANY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 166 GERMANY PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 167 GERMANY HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 168 GERMANY HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 169 GERMANY HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 170 GERMANY HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 171 GERMANY HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 172 GERMANY HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 173 GERMANY HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 174 GERMANY HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 175 GERMANY BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 176 GERMANY HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 177 GERMANY HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 178 GERMANY HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 179 GERMANY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 180 U.K. HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 181 U.K. LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 182 U.K. ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 183 U.K. HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 184 U.K. PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 185 U.K. HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 186 U.K. HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 187 U.K. HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 188 U.K. HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 189 U.K. HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 190 U.K. HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 191 U.K. HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 192 U.K. HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 193 U.K. BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 194 U.K. HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 195 U.K. HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 196 U.K. HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 197 U.K. HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 198 FRANCE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 199 FRANCE LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 200 FRANCE ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 201 FRANCE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 202 FRANCE PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 203 FRANCE HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 204 FRANCE HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 205 FRANCE HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 206 FRANCE HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 207 FRANCE HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 208 FRANCE HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 209 FRANCE HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 210 FRANCE HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 211 FRANCE BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 212 FRANCE HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 213 FRANCE HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 214 FRANCE HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 215 FRANCE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 216 SPAIN HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 217 SPAIN LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 218 SPAIN ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 219 SPAIN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 220 SPAIN PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 221 SPAIN HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 222 SPAIN HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 223 SPAIN HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 224 SPAIN HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 225 SPAIN HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 226 SPAIN HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 227 SPAIN HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 228 SPAIN HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 229 SPAIN BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 230 SPAIN HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 231 SPAIN HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 232 SPAIN HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 233 SPAIN HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 234 ITALY HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 235 ITALY LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 236 ITALY ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 237 ITALY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 238 ITALY PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 239 ITALY HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 240 ITALY HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 241 ITALY HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 242 ITALY HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 243 ITALY HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 244 ITALY HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 245 ITALY HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 246 ITALY HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 247 ITALY BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 248 ITALY HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 249 ITALY HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 250 ITALY HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 251 ITALY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 252 RUSSIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 253 RUSSIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 254 RUSSIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 255 RUSSIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 256 RUSSIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 257 RUSSIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 258 RUSSIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 259 RUSSIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 260 RUSSIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 261 RUSSIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 262 RUSSIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 263 RUSSIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 264 RUSSIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 265 RUSSIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 266 RUSSIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 267 RUSSIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 268 RUSSIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 269 RUSSIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 270 SWITZERLAND HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 271 SWITZERLAND LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 272 SWITZERLAND ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 273 SWITZERLAND HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 274 SWITZERLAND PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 275 SWITZERLAND HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 276 SWITZERLAND HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 277 SWITZERLAND HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 278 SWITZERLAND HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 279 SWITZERLAND HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 280 SWITZERLAND HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 281 SWITZERLAND HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 282 SWITZERLAND HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 283 SWITZERLAND BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 284 SWITZERLAND HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 285 SWITZERLAND HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 286 SWITZERLAND HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 287 SWITZERLAND HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 288 NETHERLANDS HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 289 NETHERLANDS LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 290 NETHERLANDS ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 291 NETHERLANDS HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 292 NETHERLANDS PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 293 NETHERLANDS HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 294 NETHERLANDS HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 295 NETHERLANDS HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 296 NETHERLANDS HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 297 NETHERLANDS HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 298 NETHERLANDS HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 299 NETHERLANDS HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 300 NETHERLANDS HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 301 NETHERLANDS BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 302 NETHERLANDS HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 303 NETHERLANDS HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 304 NETHERLANDS HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 305 NETHERLANDS HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 306 TURKEY HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 307 TURKEY LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 308 TURKEY ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 309 TURKEY HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 310 TURKEY PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 311 TURKEY HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 312 TURKEY HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 313 TURKEY HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 314 TURKEY HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 315 TURKEY HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 316 TURKEY HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 317 TURKEY HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 318 TURKEY HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 319 TURKEY BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 320 TURKEY HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 321 TURKEY HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 322 TURKEY HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 323 TURKEY HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 324 BELGIUM HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 325 BELGIUM LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 326 BELGIUM ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 327 BELGIUM HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 328 BELGIUM PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 329 BELGIUM HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 330 BELGIUM HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 331 BELGIUM HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 332 BELGIUM HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 333 BELGIUM HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 334 BELGIUM HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 335 BELGIUM HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 336 BELGIUM HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 337 BELGIUM BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 338 BELGIUM HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 339 BELGIUM HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 340 BELGIUM HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 341 BELGIUM HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 342 REST OF EUROPE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 343 ASIA-PACIFIC HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 344 ASIA-PACIFIC HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 345 ASIA-PACIFIC LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 346 ASIA-PACIFIC ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 347 ASIA-PACIFIC HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 348 ASIA-PACIFIC PARENTERAL ADMINISTRATION IN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2016-2026 (USD MILLION)

TABLE 349 ASIA-PACIFIC HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 350 ASIA-PACIFIC HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 351 ASIA-PACIFIC HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 352 ASIA-PACIFIC HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 353 ASIA-PACIFIC HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 354 ASIA-PACIFIC HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 355 ASIA-PACIFIC HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 356 ASIA-PACIFIC HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 357 ASIA-PACIFIC BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 358 ASIA-PACIFIC HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 359 ASIA-PACIFIC HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 360 ASIA-PACIFIC HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 361 ASIA-PACIFIC HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 362 JAPAN HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 363 JAPAN LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 364 JAPAN ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 365 JAPAN HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 366 JAPAN PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 367 JAPAN HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 368 JAPAN HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 369 JAPAN HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 370 JAPAN HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 371 JAPAN HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 372 JAPAN HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 373 JAPAN HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 374 JAPAN HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 375 JAPAN BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 376 JAPAN HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 377 JAPAN HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 378 JAPAN HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 379 JAPAN HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 380 CHINA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 381 CHINA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 382 CHINA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 383 CHINA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 384 CHINA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 385 CHINA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 386 CHINA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 387 CHINA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 388 CHINA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 389 CHINA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 390 CHINA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 391 CHINA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 392 CHINA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 393 CHINA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 394 CHINA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 395 CHINA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 396 CHINA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 397 CHINA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 398 SOUTH KOREA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 399 SOUTH KOREA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 400 SOUTH KOREA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 401 SOUTH KOREA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 402 SOUTH KOREA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 403 SOUTH KOREA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 404 SOUTH KOREA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 405 SOUTH KOREA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 406 SOUTH KOREA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 407 SOUTH KOREA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 408 SOUTH KOREA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 409 SOUTH KOREA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 410 SOUTH KOREA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 411 SOUTH KOREA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 412 SOUTH KOREA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 413 SOUTH KOREA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 414 SOUTH KOREA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 415 SOUTH KOREA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 416 INDIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 417 INDIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 418 INDIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 419 INDIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 420 INDIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 421 INDIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 422 INDIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 423 INDIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 424 INDIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 425 INDIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 426 INDIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 427 INDIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 428 INDIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 429 INDIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 430 INDIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 431 INDIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 432 INDIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 433 INDIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 434 AUSTRALIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 435 AUSTRALIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 436 AUSTRALIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 437 AUSTRALIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 438 AUSTRALIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 439 AUSTRALIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 440 AUSTRALIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 441 AUSTRALIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 442 AUSTRALIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 443 AUSTRALIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 444 AUSTRALIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 445 AUSTRALIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 446 AUSTRALIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 447 AUSTRALIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 448 AUSTRALIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 449 AUSTRALIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 450 AUSTRALIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 451 AUSTRALIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 452 SINGAPORE HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 453 SINGAPORE LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 454 SINGAPORE ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 455 SINGAPORE HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 456 SINGAPORE PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 457 SINGAPORE HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 458 SINGAPORE HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 459 SINGAPORE HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 460 SINGAPORE HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 461 SINGAPORE HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 462 SINGAPORE HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 463 SINGAPORE HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 464 SINGAPORE HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 465 SINGAPORE BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 466 SINGAPORE HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 467 SINGAPORE HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 468 SINGAPORE HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 469 SINGAPORE HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 470 PHILIPPINES HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 471 PHILIPPINES LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 472 PHILIPPINES ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 473 PHILIPPINES HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 474 PHILIPPINES PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 475 PHILIPPINES HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 476 PHILIPPINES HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 477 PHILIPPINES HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 478 PHILIPPINES HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 479 PHILIPPINES HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 480 PHILIPPINES HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 481 PHILIPPINES HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 482 PHILIPPINES HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 483 PHILIPPINES BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 484 PHILIPPINES HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 485 PHILIPPINES HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 486 PHILIPPINES HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 487 PHILIPPINES HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 488 INDONESIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 489 INDONESIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 490 INDONESIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 491 INDONESIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 492 INDONESIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 493 INDONESIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 494 INDONESIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 495 INDONESIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 496 INDONESIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 497 INDONESIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 498 INDONESIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 499 INDONESIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 500 INDONESIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 501 INDONESIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 502 INDONESIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 503 INDONESIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 504 INDONESIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 505 INDONESIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 506 THAILAND HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 507 THAILAND LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 508 THAILAND ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 509 THAILAND HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 510 THAILAND PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 511 THAILAND HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 512 THAILAND HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 513 THAILAND HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 514 THAILAND HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 515 THAILAND HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 516 THAILAND HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 517 THAILAND HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 518 THAILAND HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 519 THAILAND BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 520 THAILAND HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 521 THAILAND HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 522 THAILAND HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 523 THAILAND HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 524 MALAYSIA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 525 MALAYSIA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 526 MALAYSIA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 527 MALAYSIA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 528 MALAYSIA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 529 MALAYSIA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 530 MALAYSIA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 531 MALAYSIA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 532 MALAYSIA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 533 MALAYSIA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 534 MALAYSIA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 535 MALAYSIA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 536 MALAYSIA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 537 MALAYSIA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 538 MALAYSIA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 539 MALAYSIA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 540 MALAYSIA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 541 MALAYSIA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 542 REST OF APAC HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 543 SOUTH AMERICA HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 544 SOUTH AMERICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 545 SOUTH AMERICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 546 SOUTH AMERICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 547 SOUTH AMERICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 548 SOUTH AMERICA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 549 SOUTH AMERICA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 550 SOUTH AMERICA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 551 SOUTH AMERICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 552 SOUTH AMERICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 553 SOUTH AMERICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 554 SOUTH AMERICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 555 SOUTH AMERICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 556 SOUTH AMERICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 557 SOUTH AMERICA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 558 SOUTH AMERICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 559 SOUTH AMERICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 560 SOUTH AMERICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 561 SOUTH AMERICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 562 BRAZIL HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 563 BRAZIL LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 564 BRAZIL ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 565 BRAZIL HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 566 BRAZIL PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 567 BRAZIL HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 568 BRAZIL HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 569 BRAZIL HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 570 BRAZIL HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 571 BRAZIL HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 572 BRAZIL HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 573 BRAZIL HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 574 BRAZIL HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 575 BRAZIL BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 576 BRAZIL HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 577 BRAZIL HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 578 BRAZIL HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 579 BRAZIL HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 580 REST OF SOUTH AMERICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 581 MIDDLE EAST & AFRICA HEPARIN MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 582 MIDDLE EAST & AFRICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 583 MIDDLE EAST & AFRICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 584 MIDDLE EAST & AFRICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 585 MIDDLE EAST & AFRICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 586 MIDDLE EAST & AFRICA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 587 MIDDLE EAST & AFRICA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 588 MIDDLE EAST & AFRICA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 589 MIDDLE EAST & AFRICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 590 MIDDLE EAST & AFRICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 591 MIDDLE EAST & AFRICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 592 MIDDLE EAST & AFRICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 593 MIDDLE EAST & AFRICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 594 MIDDLE EAST & AFRICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 595 MIDDLE EAST & AFRICA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 596 MIDDLE EAST & AFRICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 597 MIDDLE EAST & AFRICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 598 MIDDLE EAST & AFRICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 599 MIDDLE EAST & AFRICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 600 SOUTH AFRICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 601 SOUTH AFRICA LOW MOLECULAR WEIGHT HEPARIN (LMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 602 SOUTH AFRICA ULTRA-LOW MOLECULAR WEIGHT HEPARIN (ULMWH) MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 603 SOUTH AFRICA HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 604 SOUTH AFRICA PARENTERAL ADMINISTRATION OF HEPARIN MARKET, BY MODE OF ADMINISTRATION, 2017-2026 (USD MILLION)

TABLE 605 SOUTH AFRICA HEPARIN MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 606 SOUTH AFRICA HEPARIN MARKET, BY INGREDIENTS, 2017-2026 (USD MILLION)

TABLE 607 SOUTH AFRICA HEPARIN MARKET, BY AVAILABILITY, 2017-2026 (USD MILLION)

TABLE 608 SOUTH AFRICA HEPARIN MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

TABLE 609 SOUTH AFRICA HEPARIN MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 610 SOUTH AFRICA HEPARIN MARKET, BY THERAPEUTICS, 2017-2026 (USD MILLION)

TABLE 611 SOUTH AFRICA HEPARIN MARKET, BY STRENGTH, 2017-2026 (USD MILLION)

TABLE 612 SOUTH AFRICA HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 613 SOUTH AFRICA BRANDED HEPARIN MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 614 SOUTH AFRICA HEPARIN MARKET, BY CONTAINER, 2017-2026 (USD MILLION)

TABLE 615 SOUTH AFRICA HEPARIN MARKET, BY PACKAGING, 2017-2026 (USD MILLION)

TABLE 616 SOUTH AFRICA HEPARIN MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 617 SOUTH AFRICA HEPARIN MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 618 REST OF MIDDLE EAST & AFRICA HEPARIN MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19